
No results matched your search
Sunshine Biopharma (OTCPK:SBFM +7.3%) has signed an exclusive license agreement with the University of Georgia (UGA) for two anti-coronavirus compounds which UGA had previously...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Neutral | Sell | Sell | Buy |
Technical Indicators | BUY | Strong Buy | Strong Sell | Strong Sell | Strong Buy |
Summary | Buy | Buy | Strong Sell | Strong Sell | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Engulfing Bearish | 15 | Current | |||
Upside Gap Three Methods | 30 | Current | |||
Belt Hold Bearish | 30 | Current | |||
Engulfing Bearish | 30 | Current | |||
Doji Star Bearish | 1M | Current | |||
Completed Patterns | |||||
Dragonfly Bearish | 15 | 2 | Mar 05, 2021 21:15 | ||
Doji Star Bearish | 15 | 5 | Mar 05, 2021 20:30 | ||
Engulfing Bearish | 30 | 6 | Mar 05, 2021 18:30 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | 05/03 | ||
FBN Holdings | 7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | 05/03 | ||
Guaranty Trust Bank | 31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | 05/03 | ||
UBA | 7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | 05/03 | ||
MTN Nigeria | 160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | 05/03 | ||
Oando Plc | 2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | 05/03 | ||
Access Bank | 7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | 05/03 | ||
Fidson | 4.650 | 4.650 | 4.650 | +0.240 | +5.44% | 162.29K | 05/03 | ||
Japaul Gold Ventures | 0.51 | 0.50 | 0.48 | -0.04 | -7.55% | 12.46M | 05/03 | ||
Julius Berger | 18.70 | 18.80 | 18.80 | +0.10 | +0.53% | 329.30K | 05/03 |
Sunshine Biopharma, Inc. is a pharmaceutical company. The Company focuses on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound is Adva-27a, which is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for various forms of cancer. The Company's Adva-27a is a Topoisomerase II inhibitor. Adva-27a is used against various multidrug resistant cancer cells: Breast Cancer Cells (MCF-7/MDR), Small Cell Lung Cancer Cells (H69AR), Uterine Cancer (MES-SA/Dx5) and Pancreatic Cancer (Panc-1). Adva-27a has a clearance time (half-life = 54 minutes) as indicated by human microsomes stability studies and pharmacokinetics data in rats. The Company is focuses on conducting Phase I clinical trials for Adva-27a.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review